Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Background: The stimulation of thrombin-related pathways is linked to heart failure and predicts a bad prognosis. We expected that treating patients with deteriorating chronic heart failure and underlying coronary artery illness with rivaroxaban, a factor Xa inhibitor, would decrease thrombin production and enhance results